Abstract
For monitoring ractopamine (RAC) and phenylethanolamine A (PA) with high efficiency, a novel indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) format was developed. At first, two specific monoclonal antibodies (mAbs) against RAC and PA were prepared, respectively. Based on the finding that both mAbs RAC and PA could recognize the same coating antigen RAC-SA-OVA, a novel ic-ELISA format was constructed, in which the limit of detection (LOD), recoveries, and coefficient of variation of the ic-ELISA developed for RAC residues were 0.35 μg L−1, 96.7~108.6%, and less than 6.8%, and for PA residues, they were 0.11 μg L−1, 97.8~110.2%, and less than 9.4%, respectively. The developed method also exhibited a positive correlation with the results of HPLC-MS conducted on the samples. These data indicate that the developed novel ic-ELISA is reliable and could be used in a routine application for the simultaneous determination of RAC and PA residues in swine urine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.